Related by context. All words. (Click for frequent words.) 74 taliglucerase alfa 69 UPLYSO 69 velaglucerase alfa 67 GALNS 67 REPLAGAL 66 PROMACTA 66 Phenoptin 66 Ceflatonin 66 Civacir 66 TBC# 65 forodesine 65 oral ridaforolimus 65 alvimopan 65 Biologics License Application 64 MyVax R 64 Amigal 64 EOquin 64 Fodosine 64 alvespimycin 64 refractory Hodgkin lymphoma 64 GTC recombinant human 64 Icatibant 64 ruxolitinib 64 Plicera 64 EFAPROXYN 64 Raptiva ® 64 Treatment IND 64 pseudobulbar affect PBA 64 CIMZIA TM 64 tolevamer 64 Increlex R 64 Soliris TM eculizumab 63 VPRIV 63 HuMax CD4 63 reslizumab 63 eliglustat tartrate 63 Pirfenidone 63 Uplyso 63 Aurexis 63 Zelrix 63 lumiliximab 63 Genz # 63 orBec 63 Dacogen injection 63 TREANDA 63 Zalbin 63 amrubicin 63 SEBIVO 63 severe hypercholesterolemia 63 OMNARIS HFA 63 Cellegesic 63 BLA filing 63 trastuzumab DM1 T DM1 63 registrational trial 63 Fibrillex TM 63 Golimumab 63 valopicitabine 63 PHX# 63 Nebido 63 pralatrexate 63 EOquin TM 63 Amrubicin 63 refractory chronic lymphocytic 63 SILENOR TM 63 TELINTRA 63 OncoVEX GM CSF 63 Plenaxis TM 63 herpetic keratitis 63 Zerenex 62 phase IIb clinical 62 Romiplostim 62 PEG PAL 62 sodium Injection 62 Tamibarotene 62 Biologic License Application 62 Taliglucerase alfa 62 YONDELIS 62 Archexin 62 Mipomersen 62 ponatinib 62 TRISENOX ® 62 TYZEKA 62 lomitapide 62 Pivotal Phase III 62 MAGE A3 ASCI 62 ISTODAX 62 dirucotide MBP# 62 acyclovir Lauriad R 62 ozarelix 62 HGS ETR1 62 BENLYSTA 62 refractory APL 62 Cetrorelix 62 phase IIb trial 62 Allovectin 7 ® 62 Protalix 62 Biologics Licensing 62 Azedra 62 Ixempra 62 Jevtana 62 Firazyr 62 PrevOnco 62 Combidex 62 ATPace TM 62 cintredekin besudotox 62 terlipressin 62 DAVANAT R 62 R#/MEM # 62 Linjeta TM 62 CIP TRAMADOL ER 62 AZILECT ® 62 sBLA 62 TELCYTA 62 Elagolix 62 #D#C# 62 Cloretazine ® 62 FOLOTYN 62 DAVANAT ® 62 faropenem medoxomil 62 INCB# [001] 61 Bendamustine 61 L MTP PE 61 Everolimus 61 Liprotamase 61 eltrombopag 61 HepeX B 61 Clolar 61 tezampanel 61 Gabapentin GR 61 PhosLo 61 Onalta ™ 61 FIRAZYR 61 SinuNase TM 61 Rescula 61 Fabry Disease 61 Evoltra 61 DEB# 61 Cloretazine 61 faropenem 61 PEG SN# 61 oral prodrug 61 methylnaltrexone 61 ONTAK 61 Iluvien ® 61 relapsed refractory multiple myeloma 61 SPRYCEL ® 61 Marqibo 61 LEUKINE 61 TOCOSOL Paclitaxel 61 Glufosfamide 61 Stedivaze 61 Ketotransdel ® 61 metoprolol succinate 61 Corlux 61 ATryn R 61 Marketing Authorisation Application 61 Marketing Authorization Application 61 BiovaxID TM 61 PrevOnco ™ 61 Biologics License Application BLA 61 Ventavis 61 tanespimycin 61 Joulferon 61 liprotamase 61 Bicifadine 61 LymphoStat B TM 61 Orathecin 61 Junovan 61 FOLOTYN ® 61 Androxal ® 61 maribavir 61 Octreolin 61 HepaGam B 61 octreotide implant 61 MyVax 61 OPAXIO 61 TYGACIL 61 rasagiline tablets 61 BEMA Granisetron 61 Diamyd ® 61 IL# PE#QQR 61 IMA# 61 JAK inhibitor 61 Pivotal Phase 61 Omigard 61 Urocidin 61 Ferumoxytol 61 DepoBupivacaine TM 61 dirucotide 61 AZILECT R 61 ONSOLIS 61 ALN RSV# 61 successfully commercialize Iluvien 61 Aflibercept 61 Phase IIb trials 61 Ganite R 61 vandetanib 61 Chemophase 61 orphan designation 61 NEBIDO 61 Zenpep 61 Exelbine 61 Certican 61 refractory gout 61 CIMZIA ™ 61 ONGLYZA ™ 61 StemEx 61 Rhucin ® 61 Horizant 60 NDA Submission 60 Cinryze ™ 60 MYDICAR 60 Arcalyst 60 DR Cysteamine 60 Gemzar ® 60 drug ISA# 60 ZOLINZA 60 COLAZAL 60 Ozarelix 60 Genzyme Myozyme 60 Xanafide 60 PNP inhibitor 60 Application BLA 60 Genasense ® 60 Anturol TM 60 Traficet EN 60 Technosphere Insulin 60 tafamidis 60 CINTREDEKIN BESUDOTOX 60 oxymorphone ER 60 Dextofisopam 60 Orphan Status 60 Raptiva R 60 lorcaserin NDA 60 EGRIFTA ™ 60 INCB# [002] 60 Zingo TM 60 cutaneous T cell 60 Vivaglobin 60 orBec R 60 romiplostim 60 Phase 2a trial 60 Marketing Authorization Applications 60 generation purine nucleoside 60 Naglazyme 60 GVAX 60 Nexavar sorafenib 60 BLA submission 60 chronic angina 60 Vandetanib 60 non constipation irritable 60 SUTENT 60 Fanapt TM 60 diarrhea predominant irritable 60 Genzyme Cerezyme 60 forodesine hydrochloride 60 LibiGel ® 60 RANK Ligand inhibitor 60 Proxinium TM 60 elvucitabine 60 Neuvenge 60 pegloticase 60 Campath alemtuzumab 60 Troxatyl 60 LAF# 60 Prochymal 60 glucocerebrosidase GCD 60 sorafenib tablets 60 LymphoStat B belimumab 60 Silodosin 60 BrachySil 60 GAMMAGARD 60 Onrigin 60 Canvaxin 60 ORENCIA R 60 AVASTIN 60 Hedgehog antagonist 60 thymalfasin 60 NEUMUNE 60 sargramostim 60 teduglutide 60 Rhucin 60 Fludara 60 T Pred 60 lintuzumab 60 ACTEMRA TM 60 AzaSite Plus 60 Peginterferon alfa 2b 60 Plenaxis R 60 SinuNase 60 balsalazide tablet 60 Fast Track Status 60 Pennsaid R 60 Initiate Clinical Trial 60 autologous cellular immunotherapy 60 Bezielle 60 efalizumab 60 Renvela 60 MGCD# [001] 60 Intravenous CP 60 Linjeta 60 Virulizin R 60 ACZ# 60 CDP# 60 Kynapid 60 CR# vcMMAE 60 SUTENT ® 60 BYDUREON 60 LEP ETU 60 CoFactor 60 Virulizin ® 60 Genasense R oblimersen 60 MBP# [001] 60 Genasense ® oblimersen 60 Cethromycin 60 hoFH 60 BEMA Buprenorphine 60 Ceplene 60 Pazopanib 60 cancer neuroendocrine tumor 60 anticancer compound 60 custirsen 60 Telatinib 60 Vion Pharmaceuticals 60 BEXXAR 60 torezolid phosphate 60 ORENCIA ® 60 rALLy trial 60 APTIVUS 60 Alemtuzumab 60 RAPAFLO 60 FDA Complete Response 60 anidulafungin 60 Clonicel 60 ATryn ® 60 Nexavar ® 60 VIVITROL ® 60 alglucosidase alfa 60 KIACTA ™ 60 phase III isavuconazole 60 Aviptadil 60 ganetespib 60 TRANSDUR Sufentanil 60 Sular formulation 60 Pradefovir 60 IRESSA 60 Allovectin 7 60 cinacalcet HCl 60 Bronchitol 60 Metformin GR 60 OHR/AVR# 60 Xolegel 60 AA amyloidosis 60 RSR# 59 OvaRex R 59 Targretin capsules 59 Sebivo 59 Genasense 59 Phase III Pivotal 59 ATL# [001] 59 Ambrisentan 59 elotuzumab 59 Neurodex 59 Noxafil 59 Clolar ® 59 diabetic neuropathic pain 59 ABILIFY ® 59 BYETTA ® 59 hereditary deficiency 59 bardoxolone 59 GRAS notification 59 DPX Survivac 59 Retacrit 59 rhThrombin 59 riociguat 59 Dupuytren Contracture 59 Zorbtive TM 59 Phase III Clinical Trial 59 Tezampanel 59 NUVIGIL 59 LHRH antagonist 59 Relivar 59 JOULFERON 59 Tekamlo 59 Surfaxin LS 59 Dapagliflozin 59 FavId 59 Rilonacept 59 subcutaneous formulation 59 Actemra tocilizumab 59 PRX # 59 telbivudine 59 Emselex 59 Increlex ® 59 Allovectin 7 R 59 huC# DM4 59 Clevudine 59 Loramyc R 59 cell lymphoma CTCL 59 ® decitabine 59 mRCC 59 Investigational Device Exemption 59 Torisel 59 Lumizyme 59 Emezine 59 TORISEL 59 VALSTAR 59 Itopride 59 INC# 59 Personalized Immunotherapy 59 Tracleer R 59 Viramidine 59 personalized immunotherapy 59 Hematide ™ 59 Fortical R 59 Cancidas 59 Ocrelizumab 59 ocrelizumab 59 Aryplase 59 PREZISTA 59 EGRIFTA TM 59 docetaxel Taxotere ® 59 IMiDs 59 dalbavancin 59 oxypurinol 59 refractory CLL 59 ZADAXIN 59 rThrombin 59 Phase Ib study 59 octreotide acetate 59 Dalbavancin 59 Altastaph 59 ezogabine 59 Mylotarg 59 OLEPTRO 59 lymphoma CTCL 59 canakinumab 59 methylnaltrexone bromide 59 EXALGO 59 Accelerated Approval 59 Voraxaze ™ 59 XYNTHA 59 supplemental biologics 59 Telavancin 59 MYDICAR ® 59 Azacitidine 59 Pimavanserin 59 Perifosine 59 cutaneous T 59 CTAP# Capsules 59 BEMA Fentanyl 59 Filgrastim 59 nilotinib 59 Orphan Drug designation 59 tramiprosate Alzhemed TM 59 Somatuline R Autogel R 59 PEG Interferon lambda 59 apaziquone 59 Sym# 59 MAXY G# 59 StaphVAX 59 TG# [003] 59 Leukine 59 casopitant 59 oral methylnaltrexone 59 Evoltra TM 59 Onsolis 59 SILENOR 59 mapatumumab 59 atacicept 59 Revimmune 59 visilizumab 59 MOVIPREP R 59 registrational 59 Tasigna nilotinib 59 Gleevec resistant 59 Tasimelteon 59 Ofatumumab 59 Levoleucovorin 59 gabapentin enacarbil 59 PRECISE Trial 59 lucinactant 59 ELND# 59 Campath ® 59 KRN# 59 Stavzor 59 Amoxicillin PULSYS 59 OvaRex ® MAb 59 albinterferon alfa 2b 59 Cimzia ® 59 lapatinib Tykerb 59 Cinryze 59 ISENTRESS 59 VISICOL R 59 Clofarabine 59 PXD# 59 MOZOBIL 59 AIR Insulin 59 metastatic hormone refractory 59 IIa trial 59 Voraxaze 59 FENTORA 59 CEQ# 59 PDX pralatrexate 59 RECOTHROM R 59 otelixizumab 59 humanized anti 59 Fast Track designations 59 MAA submission 59 Acetavance 59 ZADAXIN ® 59 liposomal formulation 59 Cinryze TM 59 Perforomist ™ Inhalation Solution 59 Avastin bevacizumab 59 Reverset 59 ICA # 59 SYCREST 59 Panzem R 59 Folotyn 59 Velcade bortezomib 59 BRIM2 59 Gaucher Disease 59 Xinlay 59 synthetic retinoid 59 hormone LHRH antagonist 59 MEK inhibitors 59 Oncaspar 59 E1 INT TM 59 POSIDUR TM 59 ImClone Erbitux 59 Hectorol R 59 Irinotecan 59 Genasense R 58 targeted radiotherapeutic 58 Proquin XR 58 mifamurtide 58 regorafenib 58 TEMODAL 58 Phase IIB 58 metformin HCl 58 RSD# iv 58 Meets Primary Endpoint 58 denufosol 58 omega interferon 58 THALOMID 58 abiraterone acetate 58 Degarelix 58 Amitiza 58 HCV protease inhibitor 58 Vicriviroc 58 BrachySil TM 58 receptor tyrosine kinase inhibitor 58 Triolex 58 pegylated interferon alpha 58 RIGScan CR 58 AFRESA 58 dasatinib Sprycel ® 58 axitinib 58 voclosporin 58 PLK1 SNALP 58 ATPace 58 celgosivir 58 cangrelor 58 Aptivus ® 58 Panzem R NCD 58 zanolimumab 58 Phase IIIb clinical 58 Anidulafungin 58 OFIRMEV 58 Topotecan 58 talactoferrin 58 ThermoDox R 58 BENLYSTA ® 58 refractory PTCL 58 metaglidasen 58 GLP1 agonist 58 Specifid 58 Gliadel Wafer 58 post herpetic neuralgia PHN 58 low dose cytarabine 58 ITAX 58 commercialize taliglucerase alfa 58 injectable formulations 58 pexiganan 58 INKP 58 RSD# 58 Keppra XR TM 58 Neupro R 58 Kuvan TM sapropterin 58 Phase III clinical 58 Pegintron 58 GRNVAC1 58 BAY #-# 58 brivaracetam 58 Ranexa R 58 CORT # 58 TLK# 58 Zenvia ™ 58 B CLL 58 Arzerra ofatumumab 58 Prodarsan 58 pancreatic enzyme replacement 58 LEVADEX ™ 58 Diabetic Macular Edema 58 daclizumab 58 Ostarine 58 HepaGam B TM 58 Kepivance 58 Onconase 58 PROVENGE sipuleucel T 58 IoGen 58 Azedra TM 58 Sprycel dasatinib 58 alogliptin 58 docetaxel Taxotere R 58 selective modulator 58 Onco TCS 58 Azilect ® 58 Fortovase 58 cystinosis patients 58 topical NSAID 58 NOXAFIL 58 Biologic License Application BLA 58 dextofisopam 58 Avanafil 58 GRALISE 58 AEG# 58 Restanza 58 Xcellerated T Cells 58 pegylated interferons 58 Kuvan 58 Sutent sunitinib 58 Urokinase 58 XmAb# 58 DPP4 58 PREOS 58 cannabinor 58 pegylated interferon alfa 58 Zavesca r 58 Omapro 58 Certolizumab pegol 58 Protalix BioTherapeutics 58 DORIBAX 58 lubiprostone 58 Navelbine ® 58 Entereg 58 SUMAVEL 58 inhaled AAT 58 Cimzia R 58 PS# [001] 58 paliperidone palmitate 58 Cleviprex TM clevidipine 58 Davanat 58 Arranon 58 mertansine 58 TACI Ig 58 non metastatic osteosarcoma 58 Afresa 58 SomatoKine 58 Somatuline Depot 58 decitabine 58 ularitide 58 Symbyax 58 Bayer Onyx 58 cancer immunotherapies 58 Ampligen 58 Ceflatonin ® 58 Q#IR 58 single injection viscosupplement 58 Pegloticase 58 DAVANAT 58 R alglucosidase alfa 58 Privigen 58 Abbokinase 58 ALVESCO HFA 58 ambrisentan 58 AeroLEF TM 58 sNDAs 58 HGS ETR2 58 Zavesca 58 Insegia 58 Increlex 58 ADVEXIN 58 Arimoclomol 58 Tygacil 58 ONCASPAR 58 Onalta 58 SAPHRIS 58 orally administered inhibitor 58 Fibrin Pad 58 Ketotransdel 58 Lovaxin C 58 lurasidone 58 pirfenidone 58 Cimzia TM 58 Strativa 58 TKM ApoB 58 R sorafenib tablets 58 Abstral 58 trastuzumab DM1 58 Cethrin 58 Serada 58 SIR Spheres 58 Vitaros 58 ISENTRESS raltegravir 58 Advagraf 58 castration resistant prostate cancer 58 Soliris eculizumab 58 dose escalation phase 58 Vernakalant 58 aripiprazole Abilify 58 OncoGel 58 Intermezzo R 58 acetonide FA 58 interferon beta 1b 58 GAP #B# 58 DC Bead 58 LEVADEX TM 58 Ganite ® 58 Alvesco R 58 Increlex TM 58 FDA Approvable Letter 58 relapsed multiple myeloma 58 Sandostatin LAR 58 Exherin TM 58 thrombolytic agent 58 rhC1INH 58 KNS # 58 Tekturna HCT 58 IMC A# 58 Vidaza azacitidine 58 sNDA 58 EMBEDA ™ 58 FDA Orphan Drug 58 Spiegelmer ® 58 DCVax ® Brain 58 LE SN# 58 granted Ortec 58 elagolix 58 R bendamustine hydrochloride 58 dose escalation clinical 58 Sanctura XR 58 alefacept 58 Phase IIa trial 58 Dacogen decitabine 58 Cerezyme imiglucerase 58 RoACTEMRA 58 Eculizumab 58 HuMax TAC 58 SUPPRELIN LA 58 daptomycin 58 panitumumab 58 lasofoxifene 58 PRISTIQ 58 HP Acthar Gel repository 58 phase IIa clinical 58 Vertex hepatitis C 58 AeroLEF 58 Amplimexon 58 Dabigatran etexilate 58 Zytiga 58 biologic therapy 58 cetrorelix pamoate 58 NeuroSTAT ® 58 Zebinix R 58 pitavastatin 58 Dasatinib 58 application sNDA 58 Phase #b/#a clinical 58 Dacogen 58 Complete Response 58 Enzyme Replacement Therapy 58 Phase IIb Clinical Trial 58 silodosin 58 Onbrez Breezhaler 58 Zenvia TM 58 supplemental Biologics License Application 58 REVLIMID lenalidomide 58 ATryn ® GTC recombinant 58 Alzhemed TM 58 bosutinib 58 dihydrochloride 58 Ilaris 58 OncoVEX 58 MEK inhibitor 58 TYKERB 58 capsule formulation 58 arsenic trioxide injection 58 OROS R Hydromorphone 58 recurrent metastatic ovarian cancer 58 Zelapar 57 RSD# oral 57 MAXY VII 57 XL# XL# XL# XL# 57 Mycamine 57 TOCOSOL Camptothecin 57 AP# [003] 57 SNT MC# 57 sublingual tablets 57 adult chronic ITP 57 MKC# MT 57 Initiate Phase 57 CCR5 antagonist 57 Orphan Drug Designation 57 Kit CD# positive 57 EndoTAG TM -1 57 MYCAMINE 57 Advexin 57 investigational monoclonal antibody 57 Linjeta ™ 57 markets HP Acthar 57 Vimpat R 57 Bortezomib 57 indiplon capsules 57 Ketotransdel TM 57 EVIZON TM 57 sunitinib malate 57 Tolvaptan 57 DCVax R Brain 57 Revlimid lenalidomide 57 Kamada AAT 57 Vibativ 57 PEG INTRON 57 Ramoplanin 57 ONCONASE 57 Teflaro 57 DASISION 57 Locteron ® 57 tiapamil 57 intravenous acetaminophen 57 EMSAM 57 Firdapse 57 Zenvia Phase III 57 OMAPRO 57 beta 1a 57 Anthim 57 HuLuc# 57 KYNAPID 57 Canvaxin TM 57 Annamycin 57 APEX PD 57 Proellex TM 57 Mycophenolate Mofetil 57 oral taxane 57 TREDAPTIVE 57 REMINYL ® 57 APF# 57 DIFICID ™ 57 RITUXAN 57 TheraCIM 57 omacetaxine mepesuccinate 57 XL# anticancer compounds 57 Pemetrexed 57 Phase 2b study 57 lanreotide 57 AERx iDMS 57 Hepatocellular Carcinoma HCC 57 Tarceva TM 57 THR beta agonist 57 Rituxan rituximab 57 IV acetaminophen 57 pomalidomide 57 corticosteroid dexamethasone 57 Cladribine Tablets 57 ROTATEQ 57 Hedgehog Pathway Inhibitor 57 SPARLON 57 Frova ® 57 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 57 crofelemer 57 Orphan Drug designations 57 Qutenza 57 Gencaro 57 FDA Accepts 57 PSMA ADC 57 highly purified pasteurized 57 active comparator 57 clofarabine 57 azacitidine 57 investigational therapies 57 ARIXTRA R 57 Pafuramidine 57 Riluzole 57 BCR ABL inhibitors 57 TAXUS Element Stent System 57 Votrient 57 USL# 57 Angiox 57 SUPPRELIN R LA 57 Promacta 57 iloperidone 57 Apricus Bio 57 Expanded Indication 57 refractory cutaneous T 57 investigational antiplatelet agent 57 BRIM3 57 ZEGERID Capsules 57 Argatroban 57 Xcytrin R 57 Myocet 57 HYLENEX 57 CORLUX 57 Abatacept 57 Fast Track designation 57 TRANSDUR Bupivacaine 57 Poly ICR 57 initiate Phase 1b 57 Phase III HEAT 57 Oral NKTR 57 oral cladribine 57 vemurafenib 57 Pixantrone 57 INT# [002] 57 pradefovir 57 valtorcitabine 57 Saxagliptin 57 PREZISTA r 57 StemEx R 57 acyclovir Lauriad ® 57 Puricase 57 GLASSIA 57 Vilazodone 57 FACTIVE R gemifloxacin 57 blinatumomab 57 Indaflex TM 57 sapacitabine 57 Rhucin R 57 lintuzumab SGN 57 Replagal 57 Panzem 57 ABILIFY R 57 Functional Dyspepsia 57 CytoFabTM 57 CHMP recommendation 57 radiation sensitizer 57 Rasagiline 57 Mozobil 57 Prolastin C 57 Telbivudine 57 Solasia 57 Neupro ® 57 Methylnaltrexone 57 IMC #B 57 Evoltra ® 57 Kuvan R 57 ospemifene 57 oral picoplatin 57 VIDAZA 57 lupus nephritis 57 confirmatory Phase III 57 ALN PCS 57 intranasal formulation 57 Positive Opinion 57 Pivotal Trial 57 Pralatrexate 57 Ophena TM 57 JANUVIA 57 oral rivaroxaban 57 ADVEXIN p# therapy 57 anti EGFR antibody 57 Supplemental Biologics License Application 57 Exocrine Pancreatic Insufficiency 57 Vicinium TM 57 HuMax EGFr 57 Orapred ODT 57 paclitaxel Taxol R 57 Zirgan 57 enzastaurin 57 Bosutinib 57 JAK1 57 Focalin XR 57 GA GCB 57 Fast Track Designation 57 GATTEX TM 57 Ganite 57 Sycrest 57 Exalgo 57 CCX# 57 IV Busulfex 57 nitazoxanide 57 confirmatory Phase 3 57 REOLYSIN ® 57 PEGINTRON TM 57 Gleevec imatinib 57 TMC# [002] 57 Zolinza 57 Iluvien TM 57 Urocidin TM 57 ALGRX 57 Thelin TM 57 ELADUR 57 eprodisate KIACTA TM 57 alemtuzumab Campath 57 Protexia R 57 ARIKACE 57 delivers fluocinolone acetonide FA 57 AGILECT R 57 Patient Enrollment